Blog Arasys Perfector - Xanya Sofra Weiss

Xanya Sofra-Weiss, Ph.D

WHAT IS A PACEMAKER? Each individual heartbeat is actually a collection of several muscle movements spurred into action by electrical impulses. A pacemaker is a microcurrent device emitting electrical signals causing the heart muscle to begin the contractions that comprize heartbeats.

The Pacemaker Technology For the Skeletal Muscle:

A proprietary analogue waveform sends the strenuous exercise signal to the motor nerve. This strenuous exercise signal is normally emitted by the brain.

Purpose:Pacemaker Technology for the Skeletal Muscle results in effortless movement

Necessity

* Neurological Disorders

* Muscle Atrophy

* Multiple Sclerosis

Why did it take longer to Develop the Pacemaker Technology for the Skeletal Muscle than it took to

Develop the Pacemaker? Because of the involvement of the Central Nervous System and the Brain Signal must be VERY refined and in syncwith the Nervous System or it will be.

NEURO-RESONANCE:

Neuronal synapses activated out of sync with the other inputs to the neuron stand out as odd and are eliminated. Neuronal synapses that are activated in synch with other inputs to the neuron are strengthened. In this Clinical Study we used a device built by the Co-Inventor of the Pacemaker. The device emits a dynamic, multi-sine, analogue waveform originally orchestrated in London on the basis of neuromolecular biology research. This proprietary waveform resonates the motor nerve’s signal of strenuous exercise normally emitted by the brain.

Due to its resonance with the biological signal, the Special Waveform signal of the Pacemaker Technology can spread throughout the CNS. The Special Waveform Signal eventually Reaches the Brain and triggers the following chain of biological events:

1. Brain orders the pituitary to release Growth Hormone (GF), and TSH.

4. TSH is transformed into Thyroxine (T4) and Triiodothyronine (T3)

4. T3 causes lipolysis

5. GF signals the liver to release Insulin Growth Factor (IGF-1)

6. IGF-1 causes lipolysis and muscle hypertrophy. We observed that people who received Pacemaker Technology Treatments for the Skeletal Muscle reported Looking Younger and an improved sense of wellbeing. So we decided to look at their blood. Blood transports:

1. Hormones

2. Antibodies

3. Oxygen

4. Nutrients to the cells

5.Waste products to the kidneys.

METHOD: A drop of the subject’s blood was drawn from the fingertip of each subject and placed on a microscope slide. A special lens inside the microscope projected an intimate view of the living blood onto a computer screen by way of a video camera. All subjects received 6 Ion magnum treatments. There were at least 5 pictures taken from different aspects of each sample to control for the possibility of contaminating the validity and reliability of the results by selecting a certain aspect of the sample over another. This was a blind study conducted by individuals that had not been given information as to how to interpret blood samples.

RESULTS: 97% OF THE SUBJECTS HAD A VISIBLE IMPROVEMENT IN THE DEGREE OF ERYTHROCYTE SEPARATION AFTER THE FIRST TREATMENT. Erythrocyte Separation after the first treatment was on the average limited to going from Erythrocyte Aggregation to mostly Rouleau plus some round, separated, freely moving erythrocytes.

Erythrocyte Separation after the last treatment was evident in about 85% of the subjects.

1. Clinical Treatment resulted in an overall improvement in terms of normalized erythrocyte separation.

2. On the average, RBCs separation appeared to linearly improve with increased number of treatments.

3.Clinical treatment appeared to have a negative correlation with

a. fungal forms

b. poikilocytosis

c. thrombocyte aggregation

d. bacteria

4. The enhanced erythrocyte separation as well as the reduction of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria persisted during the intervals between treatments. These highly significant results suggest that the Pacemaker Technology for the Skeletal Muscle can act as a mega antioxidant by replenishing the missing electrons of free radicals thus turning them into stable molecules.

Xanya Sofra-Weiss, Ph.D

A clinical study with individuals presenting abnormally clumped Red Blood Cells’ (RBCs) was completed in February 2009 with the Ion Magnum. Results indicate that this technology rapidly and efficiently leads to normalized erythrocytes’ separation at the microscopic level. RBCs separation is crucial for the overall blood flow and timely transport of hormones, antibodies, oxygen and nutrients to the cells, and waste products to the kidneys. Ion Magnum’s (IM) dynamic, multi-sine, analogue waveform was originally tested at the cellular level by Dr. Donald Gilbert, a molecular biologist, in the eighties. After 30 years of research, the Ion Magnum was electronically engineered by the Co-Inventor of the first Pacemaker (2008) to resonate the motor nerve’s signal of strenuous exercise normally emitted by the brain. Due to its resonance with the biological signal, the Ion Magnum signal spreads throughout the CNS inducing effortless and painless isometric and isotonic muscle contractions. The signal to the nerve ultimately triggers hormonal secretion such as Growth Hormone (GF), Thyroxine (T4) and Triiodothyronine (T3) for lipolysis and Insulin Growth Factor (IGF-1) formuscle hypertrophy.

CONCLUSION: The results of this clinical microscopy study are summarized:

1. Ion Magnum (IM) treatments result in an overall improvement in terms of normalized erythrocyte separation.

2. On the average, RBCs separation appears to linearly improve with increased number of Ion Magnum treatments.

3. Ion Magnum treatments appear to have a negative correlation with the number of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria present in the blood prior to the IM treatments, demonstrating a significant reduction of all of the above mentioned variables.

4. The enhanced erythrocyte separation as well as the reduction of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria persisted during the intervals between treatments. A longitudinal study is necessary to investigate the total length of time during which such normalization effects continue to be present. So far, two subjects that have been followed up over a period of three months have sustained the Ion Magnum’s positive effects on RBCs separation. This technology that was initially based on research associated with the Pacemaker and gained its popularity in the field of body building and cosmetic procedures is now coming full circle by offering benefits that can be potentially used in Medicine to reduce the incidence or progression of cardiac disorders resulting from erythrocyte aggregation. IM treatments effortlessly exercise the body without lactic acid production while enhancing RBCs separation. This process of exercising without actually exercising could solve the dilemma caused by intolerance to Statins which is associated with intolerance to exercise, possibly due to lactic acid formation. Statins are widely prescribed to lower high blood cholesterol and thus reduce the risk for heart disease.

Arasys Inch Loss Arasys Perfector Xanya Xanya Sofra Weiss Xanya Weiss Xanya Sorfa-Weiss Xanyasofraweiss xanyaweiss perfector arasys perfectorarasys arasysperfector inch loss inch-loss body shaping Ion Magnum Pacemaker Technology pacemaker Statins Heart Disease Heart attack Diabetes obesity cellulite cellulite loss nanotechnology nanocurrent pico amperes picoamperes picocurrent marren micro current microcurrents microcurrent face lift non surgical face lift Bio-identical Hormone Therapy Bio-identical Hormones Growth Hormone Free T3 Thyroid Hormones Muscle Building Acne Reduces acne Melasma Reduces Melasma Pigmentations Reduce Pigmentation Reduce Acne